Techlead Next Public Company Limited (SET: TL-R)
Health Care · Pharmaceuticals · TH
฿0.43
-4.44% today · 0.0% 1Y
Techlead Next Public Company Limited (SET: TL-R) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $73.04M.
Over the last twelve months the share price has gained 0.0%, trading between 0.25 and 0.50.
Tweenvest scores Techlead Next Public Company Limited across four factors: quality 53/100, value 53/100, growth 100/100. Its strongest factor is growth.
TL-R price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $73.04M
- Revenue (TTM)
- $14.23M
- P/E
- 12.06
- EPS
- 0.04
- Dividend yield
- —
- Beta (5Y)
- 0.41
- 52-week high
- ฿0.50
- 52-week low
- ฿0.25
- Avg volume (3M)
- —
- Shares outstanding
- 5.70B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Island Pharmaceuticals LimitedASX: ILA | $75.42M | AU$0.37 | -5.19% |
| Amanta Healthcare LimitedNSEI: AMANTA | $75.19M | Rs187.42 | -1.57% |
| Shield Therapeutics plcAIM: STX | $75.04M | £0.05 | -10.92% |
| Vetnostrum Animal Health Co., Ltd.TWSE: 6936 | $73.77M | NT$32.40 | +0.62% |
| Charlotte's Web Holdings, Inc.TSX: CWEB | $72.25M | CA$0.38 | 0.00% |
| PhytoHealth CorporationTWSE: 4108 | $71.75M | NT$11.55 | +1.76% |
| Domesco Medical Import - Export Joint-Stock CorporationHOSE: DMC | $71.51M | ₫53,300.00 | -2.74% |
| Cingulate Inc.NasdaqCM: CING | $71.11M | $4.89 | +2.73% |
Figures last refreshed Oct 11, 2026.